ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

Obama Nominates Regina Benjamin For Surgeon General

July 17, 2009

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980